Epidemiology of Peripartum Cardiomyopathy in Africa


  • Kamilu Karaye Department of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria
  • Abdulrazaq Habib
  • Karen Sliwa




peripartum cardiomyopathy, epidemiology, Africa, Nigeria


Peripartum cardiomyopathy (PPCM) is a disease that predominantly affects Black African women. The history of peripartum cardiac failure in Africa dates to the 1960s, before the availability of echocardiography. With the availability of echocardiography in the late 1970s, studies on well-characterised PPCM began to be reported. To date, there is no population-based PPCM study in Africa. However, hospital-based studies have reported incidence rates as high as 1:100 deliveries in Nigeria and representing up to 52% of all cardiomyopathies. For reasons that are not yet very clear, there are obvious wide disparities in incidence and prevalence within and between African Countries. Likewise, prevalence of suggested risk factors for the disease vary widely between studies. However, the disease seems to be more common among the poor rural population. Clinical outcomes are much worse in Africa than in Western Europe and North America. Mortality rates as high as 24.2% at 6 months and 47.4% at 1 year of follow-up had been recorded in Kano, Nigeria, 48.3% over 4 years in Burkina Faso, 11.6% over 6 months in Zimbabwe and 13.0% over 6 months in South Africa. It is hoped that the ongoing peripartum cardiomyopathy in Nigeria (PEACE) Registry and the worldwide EURObservational Research Programme (EORP) on PPCM will soon shed more light on the epidemiology of PPCM in Africa. The present article aimed to review the epidemiology of the disease in Africa, where the disease is relatively more common.


Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, et al. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12(8): 767-778

Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci 1937; 19: 185–199

Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van der Meer P, Roos-Hesselink JW, Seferovic P, van Spandonck-Zwarts K, Mbakwem A, Böhm M, Mouquet F, Pieske B, Hall R, Ponikowski P, Bauersachs J. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail 2017; 19(9): 1131-1141. doi: 10.1002/ejhf.780. PMID:28271625

Karaye KM, Mohammed IY, Ogah OS and Basil N Okeahialam BN. Rationale and Design for the Peripartum Cardiomyopathy in Nigeria (PEACE) Registry. International Cardiovascular Forum Journal 2017; 12: 12-17. DOI: 10.17987/icfj.v12i0.462

Seftel H and Susser M. Maternity and myocardial failure in African women. Br Heart J 1961; 23; 43-52

Brockington IF. Postpartum hypertensive heart failure. Am J Cardiol 1971; 27; 650-658

Davidson NM, Trevitt L, Parry EH. Perpartum cardiac failure. An explanation the observed geographic distribution in Nigeria. Bull World Health Organ 1974; 51(2): 203-208.

Davidson NM, Parry EH. Peri-partum cardiac failure. Q J Med 1978; 47(188): 431-461.

Sanderson JE, Adesanya CO, Anjorin FI, Parry EHO. Postpartum cardiac failure-heart failure due to volume overload? Am Heart J 1979; 97: 613-621.

Lee S, Cho GJ, Park GU, Kim LY, Lee TS, Kim DY, Choi SW, Youn JC, Han SW, Ryu KH, Na JO, Choi CU, Seo HS, Kim EJ. Incidence, Risk Factors, and Clinical Characteristics of Peripartum Cardiomyopathy in South Korea. Circ Heart Fail. 2018 Apr;11(4):e004134. doi: 10.1161/CIRCHEARTFAILURE.117.004134. PMID:29626099

Wu VC, Chen TH, Yeh JK, Wu M, Lu CH, Chen SW, Wu KP, Cheng CW, Chang CH, Hung KC, Chern MS, Lin FC, Wen MS. Clinical outcomes of peripartum cardiomyopathy: a 15-year nationwide population-based study in Asia. Medicine (Baltimore) 2017; 96(43): e8374. doi: 10.1097/MD.0000000000008374. PMID:29069030

Ersbøll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F. Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail 2017; 19(12): 1712-1720. doi: 10.1002/ejhf.882. PMID:28597481

Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol 2006; 97: 1765-1768.

Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, Ikeda T. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 2011; 75: 1975–1981

Desai D, Moodley J, Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995; 25: 118–123.

Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 2007; 17: 228–333.

Yaméogo NV, Samadoulougou AK, Kagambèga LJ, Kologo KJ, Millogo GRC, Thiam A, Guenancia C, Zansonré P. Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy. BMC Cardiovasc Disord. 2018 Jun 18;18(1):119. doi: 10.1186/s12872-018-0856-7. PMID: 29914408

Karaye KM, Sa’idu H, Habib AG. Peripartum and other cardiomyopathies in a Nigerian adult population. Int J Cardiol 2011; 147(2): 342-343.

Karaye KM, Henein MY. Peripartum cardiomyopathy: a review article. Int J Cardiol 2013; 164: 33-38.

Blauwet LA, Libhaber E, Forster O, Tibazarwa K, Mebazaa A, Hilfiker-Kleiner D, et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 2013; 99(5): 308-313.

Karaye KM, Lindmark K, Henein MY. One-year survival in Nigerians with peripartum cardiomyopathy. Heart Views 2016; 17: 55-61.

Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441–46.

Karaye KM, Yahaya IA, Lindmark K, Henein MY. Serum Selenium and Ceruloplasmin in Nigerians with Peripartum Cardiomyopathy. Int J Mol Sci 2015; 16: 7644-7654

Gambahaya ET, Hakim J, Kao D, Munyandu N, Matenga J. Peripartum cardiomyopathy among cardiovascular patients referred for echocardiography at Parirenyatwa Teaching Hospital, Harare, Zimbabwe. Cardiovasc J Afr 2017; 28(1): 8-13. doi: 10.5830/CVJA-2016-043.

Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111: 2050–2055

Gentry MB, Dias JK, Luis A, Petel R, Thornton J, Reed GL. African-American women have a higher risk for developing Peripartum cardiomyopathy. J Am Coll Cardiol 2010; 55: 654 –659.

Sheppard R, Hsich E, Damp J, Elkayam U, Kealey A, Ramani G, Zucker M, Alexis JD, Horne BD, Hanley-Yanez K, Pisarcik J, Halder I, Fett JD, McNamara DM; IPAC Investigators. GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study. Circ Heart Fail 2016; 9(3): e002683. doi: 10.1161/CIRCHEARTFAILURE.115.002683. PMID: 26915373

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–683. doi: 10.1056/NEJMoa031884.

Mebazaa A, Seronde MF, Gayat E, Tibazarwa K, Anumba DOC, Akrout N, Sadoune M, Sarb J, Arrigo M, Motiejunaite J, Laribi S, Legrand M, Deschamps L, Fazal L, Bouadma L, Collet C, Manivet P, Solal AC, Launay JM, Samuel JL, Sliwa K. Imbalanced Angiogenesis in Peripartum Cardiomyopathy - Diagnostic Value of Placenta Growth Factor. Circ J 2017; 81(11): 1654-1661. doi: 10.1253/circj.CJ-16-1193.

Bello N, Rendon IS, Arany Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J Am Coll Cardiol 2013; 62: 1715–1723. doi: 10.1016/j.jacc.2013.08.717.

Nakimuli A, Chazara O, Byamugisha J, Elliott AM, Kaleebu P, Mirembe F, Moffett A. Pregnancy, parturition and preeclampsia in women of African ancestry. Am J Obstet Gynecol 2014; 210(6): 510-520.e1. doi: 10.1016/j.ajog.2013.10.879

Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis and management. J Am Coll Cardiol 2011; 58: 659–670

Karaye KM, Habib AG. Pattern of left ventricular geometry in hypertension: a study of a hypertensive population in Nigeria. Sahel Medical Journal 2009; 12(4): 148-154.

Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Proceed 2005; 80: 1602–1606

Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006; 27: 441–46.

Okamoto H, Takenaka T, Saitoh Y. Is Hypertensive Disorder a Unique Risk Factor for Peripartum Cardiomyopathy and Pregnancy-Associated Cardiomyopathy? Circ J 2011; 75: 1827-1828.

Ntusi NBA, Badri M, Gumedze F, Sliwa K, Mayosi BM. Pregnancy-Associated Heart Failure: A Comparison of Clinical Presentation and Outcome between Hypertensive Heart Failure of Pregnancy and Idiopathic Peripartum Cardiomyopathy. PLoS ONE 2015; 10(8): e0133466. doi:10.1371/journal.pone.0133466

Karaye KM, Sani MU. The Impact of Income on the Echocardiographic Pattern of Heart Diseases in Kano, Nigeria. Niger J Med 2008; 17(3): 350-355.

Fillmore SJ, Parry EH. The evolution of peripartal heart failure in Zaria. Circulation 1977; 56: 1058-1061.

Danbauchi SS. Echocardiographic features of peripartum cardiac failure: the Zaria syndrome. Tropical Doctor 2002; 32: 24-27.

Okeke T, Ugwu E, Ezenyeaku C, Ikeako L, Okezie O. Postpartum practices of parturient women in Enugu, South East Nigeria. Ann Med Health Sci Res. 2013 Jan;3(1):47-50. doi: 10.4103/2141-9248.109486.

Tato Rocha RE, Cardenas Viedma E, Herrero Huerta E. Selenio: implicaciones fisiopatol´ogicas y cl´ınicas. Ann Med Intern 1994; 2: 457-463.

Navarro-Alarcon M, Lopez-Martinez MC. Essentiality of selenium in the human body: relationship with different diseases. The Science of the Total Environment 2000; 249: 347-371.

Cenac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. Int J Cardiol 1992; 36: 57–59.

Keshan Disease Research Group of the Chinese Academy of Medical Sciences, Beijing. Epidemiologic studies on the etiologic relationship of selenium and Keshan disease. Chin Med J (Engl.) 1979; 92: 477–482.

Fett JD, Ansari AA, Sundstrom JB, Combs GF. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 2002; 86: 311–316.

McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al; IPAC Investigators. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol 2015; 66(8): 905-914.

Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 2017; 38(35): 2671-2679. doi: 10.1093/eurheartj/ehx355.

Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997. Obstet Gynecol 2003; 102: 1326 –1331.

Merlo M, Pyxaras SA, Pinamonti B, et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011; 57(13): 1468-76. doi: 10.1016/j.jacc.2010.11.030.

Karaye KM, Lindmark K, Henein MY. Electrocardiographic predictors of peripartum cardiomyopathy. Cardiovasc J Afr 2016; 27(2): 66-70. doi: 10.5830/CVJA-2015-092.

Karaye KM. Right ventricular systolic function in peripartum and dilated cardiomyopathies. Eur J Echocardiogr 2011; 12(5): 372-374. doi: 10.1093/ejechocard/jer024.

Karaye KM, Lindmark K, Henein MY. Right ventricular systolic dysfunction and remodelling in Nigerians with peripartum cardiomyopathy: a longitudinal study. BMC Cardiovasc Disord 2016; 16: 27. doi: 10.1186/s12872-016-0204-8.

Karaye KM, Lindmark K, Henein, MY. Prevalence and predictors of right ventricular diastolic dysfunction in peripartum cardiomyopathy. J Echocardiogr 2017. DOI: 10.1007/s12574-017-0333-9

Blauwet LA, Delgado-Montero A, Ryo K, et al; IPAC Investigators. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes. Circ Heart Fail 2016; 9(5): pii: e002756. doi: 10.1161/CIRCHEARTFAILURE.115.002756

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015; 2:2. DOI: 10.17987/icfj.v2i1.4.


Additional Files